Tetrahydroindenoindole inhibits the progression of diabetes in mice

Chemico-Biological Interactions

Volumn 177, Issue 1, 2009, Pages 71-80

  Shertzer, Howard G ^a   Schneider, Scott N ^a   Kendig, Eric L ^a   Clegg, Deborah J ^b   D'Alessio, David A ^a   Johansson, Elisabet ^a   Genter, Mary Beth ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Diabetes; High fat diet; Mice; NADPH oxidase; Oxidative stress; Tetrahydroindenoindole

Indexed keywords

4B,5,9B,10 TETRAHYDROINDENO[1,2 B]INDOLE; ANTIOXIDANT; GLUCOSE; HYDROGEN PEROXIDE; INSULIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; DRUG MECHANISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HYPERINSULINEMIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIPID PEROXIDATION; LIVER MITOCHONDRION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; RESPIRATORY QUOTIENT; STREPTOZOCIN DIABETES; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; CELL RESPIRATION; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIETARY FATS; DISEASE PROGRESSION; HYPERGLYCEMIA; INDOLES; INSULIN; MICE; MITOCHONDRIA, LIVER; MODELS, BIOLOGICAL; NADPH OXIDASE; OXIDATIVE STRESS; STREPTOZOCIN;

MUS;

EID: 57349132996     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.09.001     Document Type: Article

References (39)

1. Pajvani U.B., Du X., Combs T.P., Berg A.H., Rajala M.W., Schulthess T., Engel J., Brownlee M., and Scherer P.E. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J. Biol. Chem. 278 (2003) 9073-9085
2. McTernan P.G., Kusminski C.M., and Kumar S. Resistin. Curr. Opin. Lipidol. 17 (2006) 170-175
3. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., and Feinglos M.N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37 (1988) 1163-1167
4. Vincent A.M., McLean L.L., Backus C., and Feldman E.L. Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J. 19 (2005) 638-640
5. Groop P.H., Forsblom C., and Thomas M.C. Mechanisms of disease: pathway-selective insulin resistance and microvascular complications of diabetes. Nat. Clin. Pract. Endocrinol. Metab. 1 (2005) 100-110
6. Robertson R.P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 279 (2004) 42351-42354
7. Pennathur S., and Heinecke J.W. Mechanisms for oxidative stress in diabetic cardiovascular disease. Antioxid. Redox Signal. 9 (2007) 955-969
8. Maritim A.C., Sanders R.A., and Watkins III J.B. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 17 (2003) 24-38
9. Shertzer H.G., Schneider S.N., Kendig E.L., Clegg D.J., D'Alessio D.A., and Genter M.B. Acetaminophen normalizes glucose homeostasis in mouse models for diabetes. Biochem. Pharmacol. 75 (2008) 1402-1410
10. Kendig E.L., Schneider S.N., Clegg D.J., Genter M.B., and Shertzer H.G. Over-the-counter analgesics normalize blood glucose and body composition in mice fed a high fat diet. Biochem. Pharmacol. 76 (2008) 216-224
11. Westerlund C., Ostlund-Lindqvist A.M., Sainsbury M., Shertzer H.G., and Sjoquist P.O. Characterization of novel indenoindoles. Part I. Structure-activity relationships in different model systems of lipid peroxidation. Biochem. Pharmacol. 51 (1996) 1397-1402
12. Shertzer H.G., Sainsbury M., Graupner P.R., and Berger M.L. Mechanisms of chemical mediated cytotoxicity and chemoprotection in isolated rat hepatocytes. Chem. Biol. Interact. 78 (1991) 123-141
13. Shertzer H.G., and Sainsbury M. Chemoprotective and hepatic enzyme induction properties of indole and indenoindole antioxidants in rats. Food Chem. Toxicol. 29 (1991) 391-400
14. Shertzer H.G., Sainsbury M., Reilman R., and Warshawsky D. Retardation of benzo[a]pyrene-induced epidermal tumor formation by the potent antioxidant 4b,5,9b,10-tetrahydroindeno[1,2-b]indole. Cancer Lett. 86 (1994) 209-214
15. Devitt G.P., Creagh E.M., and Cotter T.G. The antioxidant 4b,5,9b,10-tetrahydroindeno[1,2-b]indole inhibits apoptosis by preventing caspase activation following mitochondrial depolarization. Biochem. Biophys. Res. Commun. 264 (1999) 622-629
16. Brown D.W., Graupner P.R., Sainsbury M., and Shertzer H.G. New antioxidants incorporating indole and indoline chromophores. Tetrahedron 47 (1991) 4383-4408
17. Reeves P.G., Nielsen F.H., and Fahey Jr. G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123 (1993) 1939-1951
18. Woods S.C., Seeley R.J., Rushing P.A., D'Alessio D., and Tso P. A controlled high-fat diet induces an obese syndrome in rats. J. Nutr. 133 (2003) 1081-1087
19. Elder D.A., Prigeon R.L., Wadwa R.P., Dolan L.M., and D'Alessio D.A. Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults. J. Clin. Endocrinol. Metab. 91 (2006) 185-191
20. Hoover-Plow J., and Nelson B. Oxygen consumption in mice (I strain) after feeding. J. Nutr. 115 (1985) 303-310
21. Tinsley F.C., Taicher G.Z., and Heiman M.L. Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. Obes. Res. 12 (2004) 150-160
22. Senft A.P., Dalton T.P., Nebert D.W., Genter M.B., Puga A., Hutchinson R.J., Kerzee J.K., Uno S., and Shertzer H.G. Mitochondrial reactive oxygen production is dependent on the aromatic hydrocarbon receptor. Free Radic. Biol. Med. 33 (2002) 1268-1278
23. Shertzer H.G., Clay C.D., Genter M.B., Chames M.C., Schneider S.N., Oakley G.G., Nebert D.W., and Dalton T.P. Uncoupling-mediated generation of reactive oxygen by halogenated aromatic hydrocarbons in mouse liver microsomes. Free Radic. Biol. Med. 36 (2004) 618-631
24. Shen D., Dalton T.P., Nebert D.W., and Shertzer H.G. Glutathione redox state regulates mitochondrial reactive oxygen production. J. Biol. Chem. 280 (2005) 25305-25312
25. Senft A.P., Dalton T.P., Nebert D.W., Genter M.B., Hutchinson R.J., and Shertzer H.G. Dioxin increases reactive oxygen production in mouse liver mitochondria. Toxicol. Appl. Pharmacol. 178 (2002) 15-21
26. Weir G.C., and Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53 Suppl. 3 (2004) S16-S21
27. Ikemoto S., Thompson K.S., Takahashi M., Itakura H., Lane M.D., and Ezaki O. High fat diet-induced hyperglycemia: prevention by low level expression of a glucose transporter (GLUT4) minigene in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 3096-3099
28. Davidson S.M., and Duchen M.R. Endothelial mitochondria: contributing to vascular function and disease. Circ. Res. 100 (2007) 1128-1141
29. Forbes J.M., Cooper M.E., Oldfield M.D., and Thomas M.C. Role of advanced glycation end products in diabetic nephropathy. J. Am. Soc. Nephrol. 14 (2003) S254-S258
30. Stern D.M., Yan S.D., Yan S.F., and Schmidt A.M. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res. Rev. 1 (2002) 1-15
31. Genter M.B., Amarnath V., Moody M.A., Anthony D.C., Anderson C.W., and Graham D.G. Pyrrole oxidation and protein cross-linking as necessary steps in the development of gamma-diketone neuropathy. Chem. Res. Toxicol. 1 (1988) 179-185
32. Obrosova I.G., Mabley J.G., Zsengeller Z., Charniauskaya T., Abatan O.I., Groves J.T., and Szabo C. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. FASEB J. 19 (2005) 401-403
33. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., DiPietro L., Cline G.W., and Shulman G.I. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300 (2003) 1140-1142
34. Shertzer H.G., Genter M.B., Shen D., Nebert D.W., Chen Y., and Dalton T.P. TCDD decreases ATP levels and increases reactive oxygen production through changes in mitochondrial F(0)F(1)-ATP synthase and ubiquinone. Toxicol. Appl. Pharmacol. 217 (2006) 363-374
35. Pecqueur C., Alves-Guerra M.C., Gelly C., Levi-Meyrueis C., Couplan E., Collins S., Ricquier D., Bouillaud F., and Miroux B. Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J. Biol. Chem. 276 (2001) 8705-8712
36. Evans J.L. Antioxidants: do they have a role in the treatment of insulin resistance?. Indian J. Med. Res. 125 (2007) 355-372
37. Mouche S., Mkaddem S.B., Wang W., Katic M., Tseng Y.H., Carnesecchi S., Steger K., Foti M., Meier C.A., Muzzin P., Kahn C.R., Ogier-Denis E., and Szanto I. Reduced expression of the NADPH oxidase NOX4 is a hallmark of adipocyte differentiation. Biochim. Biophys. Acta 1773 (2007) 1015-1027
38. Sautin Y.Y., Nakagawa T., Zharikov S., and Johnson R.J. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am. J. Physiol. Cell Physiol. 293 (2007) C584-C596
39. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., and Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114 (2004) 1752-1761